Trending Topic

3d medical x ray of knee pain with arthritis inflammation and tendon injury, copy space
9 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The use of immune checkpoint inhibitors (ICIs) in treating cancer has greatly improved survival outcomes, particularly in patients with advanced disease for whom successful treatment options have previously been limited. For example, in patients with metastatic melanoma, the median survival time has improved from just 6 months to approximately 6 years with the use of […]

Olivier Bruyère, WCO IOF-ESCEO 2022: the Impact of Sarcopenia on Quality of Life

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 29th 2022

touchIMMUNOLOGY were delighted to catch up with Prof. Olivier Bruyère (University of Liège, Wallonia, Belgium) to discuss the impact of sarcopenia on patient quality of life.

Assessment of quality of life in sarcopenia: an urgent issue’ was presented at WCO IOF-ESCEO 2022, 24-26 March, 2022

Questions

  1. Could you give us a brief overview of sarcopenia, its prevalence, and its impact on clinical outcomes? (0:23)
  2. What is known about the association between sarcopenia and quality of life (QoL)? (2:17)

Disclosures: Olivier Bruyère discloses holding shares in SARQOL SRL.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

Filmed in coverage of the WCO IOF-ESCEO virtual meeting 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup